Sort
27,075 grants matching “cholesterol”
New pathways regulating bile acid homeostasis and cholestatic liver diseases
$325,192Li Wang · University Of Connecticut Storrs · R01 · FY2015 · DK
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism
$325,163Phillip B Hylemon · Virginia Commonwealth University · R01 · FY2012 · DK
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism
$325,163Phillip B Hylemon · Virginia Commonwealth University · R01 · FY2014 · DK
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism
$325,163Phillip B Hylemon · Virginia Commonwealth University · R01 · FY2015 · DK
Regulation of Glut 1 Function
$325,125Case Western Reserve University · R01 · FY2003 · DK
Project 1
$325,120James J Chou · Harvard Medical School · U54 · FY2011 · GM
Cholesterol metabolizing P450s: structure and function
$325,114Irina A Pikuleva · Case Western Reserve University · R01 · FY2010 · GM
Preclinical Development of the Novel Inhibitor of Apoptosis Proteins S2/IAPinh for Cancer Therapy
$325,083Dirk M. Spitzer · Medical University Of South Carolina · R01 · FY2024 · CA
APO A-1 STRUCTURAL MUTATION AND ATHEROSCLEROSIS
$325,031Wake Forest University Health Sciences · R01 · FY2001 · HL
Viral Hepatitis C and Lipid Homeostasis
$325,029Aleem Siddiqui · University Of California, San Diego · R01 · FY2010 · DK
Effects of Aging on Experimental Atherosclerosis in Nonhuman Primates
$325,025Edward Lakatta · National Institute On Aging · ZIA · FY2011 · AG
Atrogin-1 and Muscle Protein Balance
$325,001Stewart H Lecker · Beth Israel Deaconess Medical Center · R01 · FY2009 · DK
Cellular cholesterol movement and homeostasis
$325,000Yvonne Lange · Rush University Medical Center · R01 · FY2009 · HL
Discovery and evaluation of anti-filovirus therapeutics targeting NPC1
$325,000Kartik Chandran · Albert Einstein College Of Medicine, Inc · R33 · FY2015 · AI
OXIDATIVE AND ATHEROGENIC ACTION OF IN VIVO MODIFIED LDL
$325,000University Of Southern California · R01 · FY2002 · HL
OXIDATIVE AND ATHEROGENIC ACTION OF IN VIVO MODIFIED LDL
$325,000University Of Southern California · R01 · FY2003 · HL
Role of Caveolae in Signaling in Fat Cells
$325,000Paul F Pilch · Boston University Medical Campus · R01 · FY2007 · DK
OXIDATIVE AND ATHEROGENIC ACTION OF IN VIVO MODIFIED LDL
$325,000University Of Southern California · R01 · FY2004 · HL
Cholesterol Ester Hydrolysis and Cholesterol Efflux
$325,000Virginia Commonwealth University · R01 · FY2003 · HL
Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer
$324,985Joseph Anthoney Vetro · Actorius Pharmaceuticals, Llc · R41 · FY2016 · TR
Mechanisms of virus-induced impairment of reverse cholesterol transport
$324,914Michael Ilya Bukrinsky · George Washington University · R01 · FY2010 · HL
Protein degradation and cholesterol regulation
$324,869Randolph Y. Hampton · University Of California, San Diego · R37 · FY2015 · DK
Metalloenzyme Mechanisms
$324,845University Of Illinois Urbana-Champaign · R01 · FY2003 · GM
ABCA1 regulates white matter remodeling and oligodendrogenesis after stroke
$324,844Xu Cui · Henry Ford Health System · R01 · FY2015 · NS
ABCA1 regulates white matter remodeling and oligodendrogenesis after stroke
$324,844Xu Cui · Henry Ford Health System · R01 · FY2019 · NS